Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation

Myung J. Kang, Bo G. Kim, Jae Y. Eum, Sang H. Park, Sun E. Choi, Jae J. An, Sang H. Jang, Won S. Eum, Jaehwi Lee, Min W. Lee, Kyungho Kang, Chil Hwan Oh, Soo Y. Choi, Young W. Choi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In order to facilitate the intracellular delivery of macromolecules, Pep-1 peptide-modified liposomal (Pep1-Lipo) nanocarriers were designed and examined for their in vitro cell translocation capability. Pep-1 peptides were coupled via thiol-maleimide linkage to small unilamellar vesicles composed of phosphatidylcholine, Tween 80, and N-[4-(p-maleimidophenyl)butyryl]- phosphatidylethanolamine (MPB-PE). The amount of Pep-1 peptide conjugated to the vesicle was effectively controlled by the amounts of maleimide groups on the vesicular surface, ranging from 70 to 700 molecules per vesicle. Systems were evaluated for cell uptake capacity by monitoring entrapped fluorescence-labeled bevacizumab, a model protein for poorly permeable macromolecule, using confocal microscopy. The novel carriers rapidly bound to the cell membrane and migrated into the cells within 1 h, exhibiting better translocation of macromolecules compared to that of conventional liposomes. Cellular uptake of Pep1-Lipo was proportional to the amount of Pep-1 peptide on the liposomal surface. In conclusion, we found that the Pep1-Lipo formulation was a promising nanocarrier system for intracellular delivery of macromolecules.

Original languageEnglish
Pages (from-to)497-505
Number of pages9
JournalJournal of Drug Targeting
Volume19
Issue number7
DOIs
Publication statusPublished - 2011 Aug 1

Fingerprint

Drug Delivery Systems
Unilamellar Liposomes
Polysorbates
Phosphatidylcholines
Sulfhydryl Compounds
Confocal Microscopy
Liposomes
Fluorescence
Cell Membrane
Pep-1 peptide
Proteins
maleimide

Keywords

  • Cell-penetrating peptide
  • Intracellular delivery
  • Liposome
  • Macromolecule
  • Pep-1 peptide

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery : Conformational characterization and cellular uptake evaluation. / Kang, Myung J.; Kim, Bo G.; Eum, Jae Y.; Park, Sang H.; Choi, Sun E.; An, Jae J.; Jang, Sang H.; Eum, Won S.; Lee, Jaehwi; Lee, Min W.; Kang, Kyungho; Oh, Chil Hwan; Choi, Soo Y.; Choi, Young W.

In: Journal of Drug Targeting, Vol. 19, No. 7, 01.08.2011, p. 497-505.

Research output: Contribution to journalArticle

Kang, MJ, Kim, BG, Eum, JY, Park, SH, Choi, SE, An, JJ, Jang, SH, Eum, WS, Lee, J, Lee, MW, Kang, K, Oh, CH, Choi, SY & Choi, YW 2011, 'Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation', Journal of Drug Targeting, vol. 19, no. 7, pp. 497-505. https://doi.org/10.3109/1061186X.2010.511226
Kang, Myung J. ; Kim, Bo G. ; Eum, Jae Y. ; Park, Sang H. ; Choi, Sun E. ; An, Jae J. ; Jang, Sang H. ; Eum, Won S. ; Lee, Jaehwi ; Lee, Min W. ; Kang, Kyungho ; Oh, Chil Hwan ; Choi, Soo Y. ; Choi, Young W. / Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery : Conformational characterization and cellular uptake evaluation. In: Journal of Drug Targeting. 2011 ; Vol. 19, No. 7. pp. 497-505.
@article{23f0b40a1b6f40788d6df9b6bb76d1b7,
title = "Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation",
abstract = "In order to facilitate the intracellular delivery of macromolecules, Pep-1 peptide-modified liposomal (Pep1-Lipo) nanocarriers were designed and examined for their in vitro cell translocation capability. Pep-1 peptides were coupled via thiol-maleimide linkage to small unilamellar vesicles composed of phosphatidylcholine, Tween 80, and N-[4-(p-maleimidophenyl)butyryl]- phosphatidylethanolamine (MPB-PE). The amount of Pep-1 peptide conjugated to the vesicle was effectively controlled by the amounts of maleimide groups on the vesicular surface, ranging from 70 to 700 molecules per vesicle. Systems were evaluated for cell uptake capacity by monitoring entrapped fluorescence-labeled bevacizumab, a model protein for poorly permeable macromolecule, using confocal microscopy. The novel carriers rapidly bound to the cell membrane and migrated into the cells within 1 h, exhibiting better translocation of macromolecules compared to that of conventional liposomes. Cellular uptake of Pep1-Lipo was proportional to the amount of Pep-1 peptide on the liposomal surface. In conclusion, we found that the Pep1-Lipo formulation was a promising nanocarrier system for intracellular delivery of macromolecules.",
keywords = "Cell-penetrating peptide, Intracellular delivery, Liposome, Macromolecule, Pep-1 peptide",
author = "Kang, {Myung J.} and Kim, {Bo G.} and Eum, {Jae Y.} and Park, {Sang H.} and Choi, {Sun E.} and An, {Jae J.} and Jang, {Sang H.} and Eum, {Won S.} and Jaehwi Lee and Lee, {Min W.} and Kyungho Kang and Oh, {Chil Hwan} and Choi, {Soo Y.} and Choi, {Young W.}",
year = "2011",
month = "8",
day = "1",
doi = "10.3109/1061186X.2010.511226",
language = "English",
volume = "19",
pages = "497--505",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery

T2 - Conformational characterization and cellular uptake evaluation

AU - Kang, Myung J.

AU - Kim, Bo G.

AU - Eum, Jae Y.

AU - Park, Sang H.

AU - Choi, Sun E.

AU - An, Jae J.

AU - Jang, Sang H.

AU - Eum, Won S.

AU - Lee, Jaehwi

AU - Lee, Min W.

AU - Kang, Kyungho

AU - Oh, Chil Hwan

AU - Choi, Soo Y.

AU - Choi, Young W.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - In order to facilitate the intracellular delivery of macromolecules, Pep-1 peptide-modified liposomal (Pep1-Lipo) nanocarriers were designed and examined for their in vitro cell translocation capability. Pep-1 peptides were coupled via thiol-maleimide linkage to small unilamellar vesicles composed of phosphatidylcholine, Tween 80, and N-[4-(p-maleimidophenyl)butyryl]- phosphatidylethanolamine (MPB-PE). The amount of Pep-1 peptide conjugated to the vesicle was effectively controlled by the amounts of maleimide groups on the vesicular surface, ranging from 70 to 700 molecules per vesicle. Systems were evaluated for cell uptake capacity by monitoring entrapped fluorescence-labeled bevacizumab, a model protein for poorly permeable macromolecule, using confocal microscopy. The novel carriers rapidly bound to the cell membrane and migrated into the cells within 1 h, exhibiting better translocation of macromolecules compared to that of conventional liposomes. Cellular uptake of Pep1-Lipo was proportional to the amount of Pep-1 peptide on the liposomal surface. In conclusion, we found that the Pep1-Lipo formulation was a promising nanocarrier system for intracellular delivery of macromolecules.

AB - In order to facilitate the intracellular delivery of macromolecules, Pep-1 peptide-modified liposomal (Pep1-Lipo) nanocarriers were designed and examined for their in vitro cell translocation capability. Pep-1 peptides were coupled via thiol-maleimide linkage to small unilamellar vesicles composed of phosphatidylcholine, Tween 80, and N-[4-(p-maleimidophenyl)butyryl]- phosphatidylethanolamine (MPB-PE). The amount of Pep-1 peptide conjugated to the vesicle was effectively controlled by the amounts of maleimide groups on the vesicular surface, ranging from 70 to 700 molecules per vesicle. Systems were evaluated for cell uptake capacity by monitoring entrapped fluorescence-labeled bevacizumab, a model protein for poorly permeable macromolecule, using confocal microscopy. The novel carriers rapidly bound to the cell membrane and migrated into the cells within 1 h, exhibiting better translocation of macromolecules compared to that of conventional liposomes. Cellular uptake of Pep1-Lipo was proportional to the amount of Pep-1 peptide on the liposomal surface. In conclusion, we found that the Pep1-Lipo formulation was a promising nanocarrier system for intracellular delivery of macromolecules.

KW - Cell-penetrating peptide

KW - Intracellular delivery

KW - Liposome

KW - Macromolecule

KW - Pep-1 peptide

UR - http://www.scopus.com/inward/record.url?scp=78650804761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650804761&partnerID=8YFLogxK

U2 - 10.3109/1061186X.2010.511226

DO - 10.3109/1061186X.2010.511226

M3 - Article

C2 - 20738150

AN - SCOPUS:78650804761

VL - 19

SP - 497

EP - 505

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 7

ER -